FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

FDA Clears 2 Pentax Endoscopes

FDA clears Pentax Medical 510(k)s for new endoscope models for colonoscopy and upper GI use.

latest-news-card-1
Federal Register

Guide on Standardized BIMO eSubmission Data

Federal Register notice: FDA makes available a guidance entitled Standardized Format for Electronic Submission of NDA and BLA Content for the Planning...

latest-news-card-1
Medical Devices

Update on Baxter Recall of Hemodialysis Transfer Sets

FDA updates a Baxter recall (device correction) of its MiniCap Extended Life PD Transfer Sets used in hemodialysis.

latest-news-card-1
Human Drugs

GSK Files for Nucala COPD Indication

FDA accepts for review a supplemental NDA for Nucala (mepolizumab) and its use as an add-on maintenance treatment for patients with chronic obstructiv...

latest-news-card-1
Human Drugs

Simplified Dosing for Cumberlands Acetadote OKd

FDA approves a Cumberland Pharmaceuticals supplemental NDA for a simplified dosing regimen of its Acetadote (N-acetylcysteine for injection).

latest-news-card-1
Human Drugs

Mixed Results on Keytruda Ovarian Cancer Study

Merck says a Phase 3 KEYLYNK-001 trial evaluating Keytruda (pembrolizumab) plus chemotherapy followed by maintenance with Lynparza (olaparib) met the...

latest-news-card-1
Human Drugs

Agios Seeks Expanded Use for Pyrukynd

Agios files a supplemental NDA for an expanded indication for its Pyrukynd (mitapivat) for treating adult patients with alpha- or beta-thalassemia.

latest-news-card-1
Medical Devices

FDA Clears Prostate Tissue Ablator

FDA clears an AngioDynamics 510(k) for the NanoKnife System for prostate tissue ablation.

latest-news-card-1
Human Drugs

AbbVie Reports Positive Parkinsons Trial Data

AbbVie announces positive topline results from its pivotal Phase 3 TEMPO-2 trial evaluating tavapadon as an early Parkinson's disease therapy.

latest-news-card-1
Human Drugs

Chimerix Plans Accelerated Approval NDA for Gliomas Drug

Chimerix plans to submit an NDA before the end of the year seeking accelerated approval for dordaviprone for treating recurrent H3 K27M-mutant diffuse...